Osimertinib 80 mg in India: Brands, Availability and Sourcing Guide for Hospitals (2026)
Osimertinib has become the reference treatment for EGFR-mutated non-small cell lung cancer (NSCLC), and hospital pharmacies, oncology centres and chemists across India now field the same questions again and again: which osimertinib 80 mg brands are in the market, how do they differ, and how can a buyer confirm that stock is genuine and correctly […]
Imfinzi (Durvalumab) in India 2026 — What Hospitals and Oncology Centres Need to Know
Imfinzi is one of the most searched oncology medicines on akpharma.in — generating over 1,400 impressions per month at position 6 on Google, with a click-through rate that suggests the page is being found but not telling visitors enough to bring them through. This article fills that gap. Whether you are a hospital pharmacist managing […]
